首页> 外文期刊>Bioethics >EQUALITY AND THE TREATMENT-ENHANCEMENT DISTINCTION
【24h】

EQUALITY AND THE TREATMENT-ENHANCEMENT DISTINCTION

机译:平等与待遇增强的区别

获取原文
获取原文并翻译 | 示例
           

摘要

In From Chance to Choice, Allen Buchanan, Dan Brock, Norman Daniels and Daniel Wikler propose a new way of defending the moral significance of the distinction between genetic treatments and enhancements. They develop what they call a ‘normal function model’ of equality of opportunity and argue that it offers a ‘limited’ defence of this distinction. In this article, I critically assess their model and the support it (allegedly) provides for the treatment-enhancement distinction. First, I argue that there is a troubling tension in the normal function model. Secondly, I argue that neither of the rationales invoked by Buchanan et?al. really serves to justify this model or the results they seek to derive from it with respect to the significance of the distinction between treatments and enhancements.
机译:艾伦·布坎南(Allen Buchanan),丹·布罗克(Dan Brock),诺曼·丹尼尔斯(Norman Daniels)和丹尼尔·威克勒(Daniel Wikler)在《从机会到选择》中提出了一种捍卫基因治疗与增强治疗之间区别的道德意义的新方法。他们开发了机会均等的“正常功能模型”,并认为它为这种区别提供了“有限的”辩护。在本文中,我会严格评估它们的模型及其(据称)为增强治疗提供的支持。首先,我认为正常功能模型中存在令人不安的紧张局势。其次,我认为布坎南(Buchanan)等人没有引用任何理论依据。就治疗和增强之间区别的重要性而言,确实可以证明该模型或他们试图从中得出的结果是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号